Southwest Annual Conference

Location: Houston, TX
Date: March 20-22, 2014

Meeting Overview

Venue:
George R. Brown Convention Center
Primary Audience:
Primary Care
Credits:
Please refer to the Accreditation Tab

Registration is now closed

For those who look to you—you can look to us.

Primary care is where good health begins. It is based on your relationship with your patients as you provide and coordinate the care they need, from preventive health to specialty care to inpatient services. The demands and challenges you face every day within your practice are constantly changing, so we’re changing with you.

We’ve taken the feedback of clinicians in your region and across the country to launch an all-new Annual Conference.

Pri‑Med has expanded its partnership with the American College of Physicians (ACP), and in collaboration with the ACP we will be unveiling an entirely new cutting-edge CME curriculum. The CME sessions will include the latest treatments and therapies, such as:

  • Live Demonstration Orthopedic Exam: See It, Do It
  • Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
  • Lung Sounds: A Primer on Pulmonary Auscultation

View the full session schedule»

But that’s not all…

In addition to over 24 new educational sessions covering 15 different therapeutic areas, there are many new components of the conference that were created with you in mind.

  • Join us on Thursday night for an Opening Night Reception with complimentary cocktails and hors d’oeuvres
  • SAFE Opioid Prescribing certification sessions featuring a faculty meet and greet and book signing
  • Two renowned Keynote Speakers, Dr. Michael Dansinger, a weight loss and nutrition consultant for NBC’s “The Biggest Loser”, and Dr. Story Musgrave, former NASA astronaut and part-time trauma surgeon.

Keynote speaker sneak peeks »

Earn up to 20.75 AMA PRA Category 1 Credits™ or 20.75 AANP contact hours of continuing education by attending all 3 days.

 

Register for Pri‑Med Southwest by: Your price**
December 5 $30
January 16 $40
February 27 $55
March 16 $75
Onsite at Pri‑Med Southwest $80

*Primary Care Updates tracks are sponsored by pmiCME and are produced independently of and are not affiliated with the American College of Physicians. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

**Price represents online registration; registration by phone is an additional $10.

Good Health Begins Here

Comprehensive CME Program

Primary Care Updates*
March 20, 2014
A multi-track day of CME programs to supplement your education. Earn up to 6.75 AMA PRA Category 1 Credits™ or 6.75 AANP contact hours of continuing education.

Annual Conference
March 21–22, 2014
An entirely new cutting-edge CME curriculum developed in collaboration with the American College of Physicians. Earn up to 14 AMA PRA Category 1 Credits™ or 14 AANP contact hours of continuing education.


Educational Symposia
Accredited CME sessions to expand your learning during breaks from the core ACP curriculum.


Industry-sponsored Opportunities

Exhibit Hall
Have face-to-face conversations with industry professionals, gain helpful takeaways, and experience engaging floor activities such as live demonstrations, outside your office hours. Learn More »

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.


Distribution of all additional opportunity tickets will happen on-site on a first-come, first-served basis at the Ticket Booth. Please check-in early to ensure tickets are available for the additional opportunities you want to participate in.

Presentation Theaters are not offered for CME credit nor is the content planned or reviewed by pmiCME or ACP.

 

Pri-Med Mobile App Available Now!

Sessions & Syllabus

For your convenience, we have printer-friendly syllabus slides available for you to download.

Print Primary Care Updates Syllabus

CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
Tools for Diagnosis, Assessment, and Management of Chronic Obstructive Pulmonary Disease in Clinical Practice
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Utilize recommendations, such as those of the Global initiative for chronic Obstructive Lung Disease (GOLD) and the Chronic Obstructive Pulmonary Disease (COPD) Foundation, for diagnosis of COPD, including use of spirometry and evaluation of symptoms.
  2. Evaluate and differentiate between standard COPD therapies for decreasing exacerbations and improving symptoms and other outcomes.
  3. Integrate recently approved agents into the COPD treatment armamentarium through evidence-based decision making.
Faculty:
  1. Jill Ohar, MD, Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine, Center for Genomics and Personalized Medicine Research, Comprehensive Cancer Center, Center for Worker Health, Director for Respiratory Therapy, Wake Forest Baptist HealthWinston-Salem, NC
  2. Fernando Martinez, MD, MS, Professor, Department of Internal Medicine, Director, Pulmonary Diagnostic Services, University of MichiganAnn Arbor, MI
CLOSE  X  
Managing the Patient with High Triglycerides: Assessment and Treatment Strategies
Room: Hall B3, Level 3
Learning Objectives:
  1. Discuss the role of elevated triglyceride levels in the assessment and diagnosis of dyslipidemia, including cardiovascular risk factors.
  2. Apply best practices in the attainment of TG levels, including the role of fasting and non-fasting states in accurate evaluation.
  3. Evaluate the management of hypertriglyceridemia through greater adherence to evidenced based practices and accepted guidelines.
  4. Select potential new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk.
Faculty:
  1. JoAnne Foody, MD, FACC, FAHA, Medical Director, Pollin Cardiovascular Wellness Program, Brigham and Women's HospitalBoston, MA, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
  2. Gregory Pokrywka, MD, NCMP , FACP , FNLA, Assistant Professor of Medicine, Johns Hopkins University School of MedicineBaltimore, MD, Director, Baltimore Lipid CenterBaltimore, MD, Diplomate, American Board of Clinical LipidologyJacksonville, FL (Bio)
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
Chronic Obstructive Pulmonary Disease - Practical Approaches to Diagnosis and Management
Room: Hall B3, Level 3
Learning Objectives:
  1. Evaluate the role of spirometry in COPD diagnosis and monitoring.
  2. Review recommended pharmacologic interventions to reduce COPD symptoms and decrease exacerbations.
  3. Select appropriate patient counseling strategies.
Faculty:
  1. Barbara Yawn, MD, MSc, FAAFP, Director of Research, Olmsted Medical Center Rochester, MN, Adjunct Professor, Department of Family and Community Health, University of MinnesotaMinneapolis, MN
  2. Fernando Martinez, MD, MS, Executive Vice Chair, Department of Medicine, Weill Cornell Medical CenterNew York, NY
CLOSE  X  
Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Implement treatment regimens for patients with type 2 diabetes in accordance with recently updated treatment recommendations.
  2. Review the clinical evidence for the use of incretin-based therapies in type 2 diabetes management.
Faculty:
  1. Jeff Unger, MD, FACE , ABFM, Assistant Professor of Family Medicine, Loma Linda University School of MedicineRiverside, CA, Medical Director, The Unger Primary Care Medical CenterChino, CA, Associate Director of Metabolic Studies, Catalina Research InstituteChino, CA
  2. Jack Leahy, MD, Professor of Medicine, Chief, Division of Endocrinology, Diabetes and Metabolism, The University of VermontColchester, VT (Bio)
  3. Javier Morales, MD, Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PCGreat Neck, NY (Bio)
CLOSE  X  
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
Room: Hall B3, Level 3
Learning Objectives:
  1. Summarize fundamental similarities and differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet drugs.
  2. Explain efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials.
  3. Recognize guideline-based therapies to reduce risk and goals to achieve in the management of patients who have experienced an acute coronary syndrome.
Faculty:
  1. James de Lemos, MD, Professor of Medicine, University of Texas Southwestern Medical SchoolDallas, TX (Bio)
  2. Jeffrey Anderson, MD, FACC, FAHA, MACP, Professor of Internal Medicine, University of Utah School of MedicineSalt Lake City, UT
CLOSE  X  
Working Against the Clock: Practical Strategies for Diagnosis and Management of Shift Work Disorder
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Describe the pathophysiologic basis of circadian rhythm misalignment and its relationship to sleep/wakefulness and overall health.
  2. Establish the differential diagnosis of SWD based on symptomatology, patient history, and findings obtained from a thorough sleep history and other assessment tools.
  3. Formulate evidence-based initial and ongoing treatment plans for SWD that incorporate nonpharmacologic and pharmacologic modalities.
Faculty:
  1. Paul Doghramji, FAAFP , MD, Attending Physician, Collegeville Family PracticeCollegeville, PA, Medical Director of Health Services, Ursinus CollegeCollegeville, PA (Bio)
  2. Max Hirshkowitz, PhD, Professor, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of MedicineHouston, TX, VA Medical CenterHouston, TX
CLOSE  X  
Lunch
CLOSE  X  
Lunch
CLOSE  X  
Digesting the Facts in IBS: From Early Diagnosis to Effective Treatment Options
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Evaluate the necessity of diagnostic testing in individual patients prior to diagnosis of IBS.
  2. Choose appropriate nonpharmacologic or pharmacologic therapies to aid patients with IBS.
  3. Manage the symptoms of IBS over the long term through effective treatment strategies.
Faculty:
  1. Brian Lacy, MD, PhD, Professor of Medicine, Dartmouth Medical SchoolLebanon, NH, Chief, Section of Gastroenterology and Heptology, Dartmouth Hitchcock Medical CenterLebanon, NH (Bio)
  2. Spencer Dorn, MD, MPH, MHA, Assistant Professor of Medicine, Vice Chief of Gastroenterology, Lead Information Physician, EPIC, University of North Carolina Chapel Hill, NC
CLOSE  X  
Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
Room: Hall B3, Level 3
Learning Objectives:
  1. Recognize the role of the renal system in glucose uptake, reabsorption, and the maintenance of glucose homeostasis and use the achieved knowledge to identify patients who would benefit from renally-targeted therapies.
  2. Explain the mechanism of action of sodium glucose linked transporter inhibitors and their role in modulating glucose homeostasis.
  3. Review professional guidelines from the ADA and AACE for target goals of therapy and treatment recommendations for specific patient-types.
  4. Identify the safety and efficacy profiles of current and emerging therapies that target renally-mediated glucose uptake and reabsorption.
  5. Implement management strategies that incorporate current and emerging therapies into treatment paradigms for patients who would benefit from a targeted approach to glycemic control.
Faculty:
  1. Charles Reasner, MD, II, Adjunct Professor, Department of Medicine, Diabetes Division, University of Texas Health Science Center at San AntonioSan Antonio, TX, Staff Physician, Diabetes AmericaSan Antonio, TX
CLOSE  X  
PM Break
CLOSE  X  
PM Break
CLOSE  X  
Key Strategies for HPV Cancer Prevention
Room: Hall B3, Level 3
Learning Objectives:
  1. Explain the epidemiology and burden of disease associated with HPV viruses.
  2. Identify those HPV types most often associated with particular cancers and genital warts.
  3. Discuss strategies to reduce the prevalence of these diseases.
  4. Discuss how vaccine safety is assessed and monitored.
Faculty:
  1. Kenneth Alexander, MD , PhD, Professor of Pediatrics, Chief, Section of Pediatric Infectious Diseases, University of Chicago Chicago, IL
  2. Rachel Caskey, MD, MPP, Program Director, Med-Peds, Associate Section Chief, General Internal Medicine, Associate Section Chief, General Pediatrics, University of Illinois at ChicagoChicago, IL
CLOSE  X  
Current Perspectives and Emerging Approaches in Lipid Management
Room: George Bush Ballroom, Level 3
Learning Objectives:
  1. Evaluate primary and secondary prevention evidence with statins.
  2. Explain the importance of lowering LDL-C for reducing cardiovascular risk, interpret statin safety data, and assess benefit/risk with statins.
  3. Explain the association of hypertriglyceridemia with increased risks and identify currently available therapies for reducing elevated triglycerides.
  4. Discuss similarities and differences between currently available and emerging omega-3 fatty acid agents, and indicate patient populations for potential incorporation of omega-3 fatty acids in clinical practice.
Faculty:
  1. JoAnne Foody, MD, FACC, FAHA, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
  2. Terry Jacobson, MD, FACP, Professor of Medicine, Emory UniversityAtlanta, GA
Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Supported by an educational grant from Amarin Pharma, Inc., AstraZeneca and Merck & Co., Inc.
Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Forest Laboratories, Inc., Novo Nordisk Inc., Teva CNS , Forest Laboratories, Inc. and Ironwood Pharmaceuticals. and AstraZeneca.
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
  
  
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:45 AM-9:00 AM
Managing the Patient with High Triglycerides: Assessment and Treatment Strategies
7:45 AM-9:00 AM
Tools for Diagnosis, Assessment, and Management of Chronic Obstructive Pulmonary Disease in Clinical Practice
  
  
  
  
9:00 AM-9:15 AM - AM Break
9:00 AM-9:15 AM - AM Break
9:15 AM-10:30 AM
Chronic Obstructive Pulmonary Disease - Practical Approaches to Diagnosis and Management
9:15 AM-10:45 AM
Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014
  
  
  
  
10:30 AM-12:00 PM
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
 
 
10:45 AM-12:00 PM
Working Against the Clock: Practical Strategies for Diagnosis and Management of Shift Work Disorder
  
  
  
  
12:00 PM-12:30 PM - Lunch
12:00 PM-12:30 PM - Lunch
  
12:30 PM-1:45 PM
Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
12:30 PM-1:45 PM
Digesting the Facts in IBS: From Early Diagnosis to Effective Treatment Options
  
  
  
  
1:45 PM-2:00 PM - PM Break
1:45 PM-2:00 PM - PM Break
2:00 PM-3:15 PM
Key Strategies for HPV Cancer Prevention
2:00 PM-3:30 PM
Current Perspectives and Emerging Approaches in Lipid Management
  
  
  
  
  
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
Room: Hall B3, Level 3
Getting your patients to lose weight is never easy. Learn in this keynote address from the weight loss and nutrition consultant to NBC's "The Biggest Loser" about effective lifestyle and behavioral approaches to achieve weight loss goals in your overweight and obese patients.
Learning Objectives:
  1. Employ proven, evidence-based lifestyle and behavioral modalities to help your obese patients lose weight and achieve health benefits.
Faculty:
  1. Michael Dansinger, MD, Director of the Diabetes Reversal Program, Tufts Medical CenterBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
Room: George Bush Ballroom, Level 3
This session will provide new insight into the pathogenesis of dyslipidemia in the type 2 diabetic patient with chronic kidney disease and the rationale for advanced lipid testing (i.e., lipoprotein particle analysis) in those patients at high CV risk.
Learning Objectives:
  1. Describe the pathogenesis of dyslipidemias in patients with diabetes and chronic kidney disease.
  2. Understand the rationale for performing lipoprotein particle analysis in patients with high CV risk comorbidities.
Faculty:
  1. Matthew Sorrentino, FASH , MD, FACC, Professor of Medicine, Department of Medicine, Section of Cardiology, University of Chicago Pritzker School of MedicineChicago, IL (Bio)
CLOSE  X  
Live Demonstration Orthopedic Exam: See It, Do it
Room: Hall B3, Level 3
Learn orthopedic maneuvers to assess common office-based musculoskeletal complaints.
Learning Objectives:
  1. Through live demonstration of orthopedic maneuvers, you will improve your ability to diagnose common musculoskeletal complaints of the upper body, low back, hip, and knee.
Faculty:
  1. Christopher Smith, MD, FACP, Associate Proessor of Medicine, Harvard Medical SchoolBoston, MA, Associate Director, Internal Medicine Residency Program, Co-Director, Rabkin Fellowship in Medical Education, Beth Israel Deaconess Medical CenterBoston, MA (Bio)
CLOSE  X  
Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic
Room: George Bush Ballroom, Level 3
Non-alcoholic fatty liver disease is seen in many patients who are overweight or obese, or have diabetes, high cholesterol or high triglycerides. This session will review the spectrum of this condition, risk factors, referral advice, and application of the most current evidence-based recommendations for management.
Learning Objectives:
  1. Identify the risk factors and disease spectrum of non-alcoholic fatty liver disease.
  2. Apply the latest evidence-based recommendations for the management of NAFLD.
  3. Understand the indications for liver biopsy and further investigation.
Faculty:
  1. Julia Wattacheril, MD, MPH, Assistant Professor, Medicine, Columbia University College of Physicians and SurgeonsNew York, NY, Adjunct Assistant Professor of Medicine, Medicine, Weill Cornell Medical CollegeNew York, NY, Attending Physician, Medicine, New York Presbyterian HospitalNew York, NY (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
Room: George Bush Ballroom, Level 3
Elderly patients with dementia present the practicing physician with the challenge of managing the psychiatric and behavioral spectrum of this disorder: memory problems, mood disorders, sleep disturbances, apathy, delusions, hallucinations, wandering and agitation. This session will provide assistance in the differential diagnosis and the selection of appropriate pharmacologic and non-pharmacologic treatments for behavioral problems.
Learning Objectives:
  1. Differentiate the variation in symptoms of the dementing disorders depending upon their etiology.
  2. Apply appropriate pharmacologic therapies for behavioral problems associated with dementia.
  3. Apply appropriate non-pharmacological therapies for agitation with special attention to the environment.
Faculty:
  1. Katherine Galluzzi, FACOFP , DO, CMD, Professor and Chairperson, Department of Geriatric Medicine, Department of Geriatric MedicinePhiladelphia, PA, Director, Comprehensive Care @ PCOM, Philadelphia College of Osteopathic MedicinePhiladelphia, PA, Medical Director, Hospice of Philadelphia, VNA of Greater PhiladelphiaPhiladelphia, PA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
Room: Hall B3, Level 3
Practicing clinicians face the challenge of evaluating patients for aberrant drug behavior when prescribing opioid therapy for pain management. This session will help improve your ability to identify risk factors for drug-seeking behaviors and to differentiate between opioid tolerance, physical dependence and addiction.
Learning Objectives:
  1. Identify risk factors for opioid-related aberrant behavior.
  2. Differentiate between tolerance, physical dependence and addiction.
Faculty:
  1. Charles Argoff, MD, Assistant Professor of Neurology, New York University School of MedicineNew York, NY, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
Room: Hall B3, Level 3
Improve your ability to adjust treatment when converting from immediate release opioid formulations to extended release/long-acting preparations, as well as your ability to identify risk factors for opioid-induced respiratory depression.
Learning Objectives:
  1. onvert patients from immediate-release to ER/LA opioids as well as from one ER/LA opioid to another
  2. Identify predisposing risk factors for significant respiratory depression.
Faculty:
  1. Bill McCarberg, MD, Founder, Chronic Pain Management ProgramSan Diego, CA (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Test Your Skills in Difficult Cases: Atrial Fibrillation
Room: George Bush Ballroom, Level 3
This session will provide important take away information on the use of anticoagulant therapy in afib patients that is evidence and guideline based. Also included will be approaches to differentiate between rate and rhythm control that can direct appropriate treatment strategies.
Learning Objectives:
  1. Describe current guidelines and clinical evidence regarding the use of anticoagulant therapy in patients with atrial fibrillation (AF).
  2. Differentiate between rate and rhythm control in AF and direct appropriate treatment strategies based on these parameters.
Faculty:
  1. Jordan Prutkin, MD, MHS, Assistant Professor of Medicine, Division of Cardiology/Electrophysiology, University of Washington Seattle, WA
CLOSE  X  
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
Room: Hall B3, Level 3
Improve your ability to manage adverse reactions with extended release/long-acting opioid formulations and to monitor patient adherence to treatment.
Learning Objectives:
  1. Evaluate and manage adverse effects of ER/LA-opioids.
  2. Differentiate strategies for monitoring patient adherence.
Faculty:
  1. Bill McCarberg, MD, Founder, Chronic Pain Management ProgramSan Diego, CA (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Networking Break
CLOSE  X  
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
Room: George Bush Ballroom, Level 3
Sequential insulin strategies recommended by the ADA/EASD will be reviewed, and evidence-based insulin regimens will be provided that can be used to initiate treatment that gets type 2 diabetic patients to their A1c goals.
Learning Objectives:
  1. Describe the sequential insulin strategies approach recommended by recent guidelines.
  2. Apply evidence-based insulin strategies to help patients with type 2 diabetes achieve their HbA1C goals.
Faculty:
  1. Javier Morales, MD, Vice President, Principal Clinical Trails Investigator, Advanced Internal Medicine GroupNew Hyde Park, NY, St. Francis Hospital, Advanced Internal Medicine GroupNew Hyde Park, NY (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
Room: Hall B3, Level 3
This session will provide important take away strategies for counseling patients and caregivers to ensure appropriate use of extended release/long-acting opioids and recognition of signs of overdose.
Learning Objectives:
  1. Implement counseling strategies to ensure patients know to take ER/LA opioids exactly as prescribed.
  2. Use counseling strategies to explain signs of ER/LA opioid overdose to patients and caregivers.
Faculty:
  1. Steven Stanos, DO, Medical Director, Center for Pain Management, Rehabilitation Institute of ChicagoChicago, IL, Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
Room: Hall B3, Level 3
When individualizing your pain management treatment approach, learn how to assess differences in opioid metabolism and potential drug interactions in your patient, and how these factors will impact treatment.
Learning Objectives:
  1. Assess the differences in opioid metabolism and how these impact appropriate ER/LA prescribing.
  2. Identify how opioid-drug interactions influence ER/LA opioid prescribing.
Faculty:
  1. Steven Stanos, DO, National Director, Corporate Pain Services, Attending Physician, Center for Pain Management, Rehabilitation Institute of ChicagoChicago, IL, Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
Room: George Bush Ballroom, Level 3
Improve your recognition of the signs and symptoms of major depressive disorder with differentiation from bipolar disorder. Improve your knowledge in the best practice selection of pharmacologic treatments for patients with uncomplicated depression and somatization.
Learning Objectives:
  1. Recognize the signs and symptoms of major depressive disorder (MDD) and initiate therapy with close monitoring.
  2. Differentiate bipolar disease from symptoms of depression in order to determine appropriate treatment.
  3. Consider actions and side effects of drugs and drug classes when deciding on which treatment to select for patients with psychiatric disorders.
Faculty:
  1. Marius Commodore, MD, Associate Professor of Medicine & Psychiatry, Section of General Internal Medicine, Temple University School of MedicinePhiladelphia, PA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
Room: Hall B3, Level 3
Improve your understanding of the official prescribing information for available extended release/long-acting opioids, as well as the doses indicated for opioid-tolerant patients.
Learning Objectives:
  1. Differentiate the prescribing information among available ER/LA opioids.
  2. Identify ER/LA opioids and dosages indicated for opioid-tolerant patients only.
Faculty:
  1. Charles Argoff, MD, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Medical Brain Game: SAFE Opioid Prescribing Edition
Room: Hall B3, Level 3
This session makes use of an engaging quiz show format to reinforce the essential elements in the appropriate use of opioids in pain management.
Learning Objectives:
  1. Compete in this practical, REMS-themed medical knowledge game, sure to provide a fun challenge.
Faculty:
  1. Charles Argoff, MD, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
  2. Bill McCarberg, MD, Founder, Chronic Pain Management Program, Kaiser Permanente San Diego, CA (Bio)
  3. Steven Stanos, DO, Medical Director, Center for Pain Management, Rehabilitation Institute of ChicagoChicago, IL, Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-11:45 AM
Live Demonstration Orthopedic Exam: See It, Do it
9:45 AM-10:45 AM
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
 
 
 
10:45 AM-11:45 AM
Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:30 PM
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
1:45 PM-2:45 PM
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
 
 
2:30 PM-3:00 PM
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
2:45 PM-3:45 PM
Test Your Skills in Difficult Cases: Atrial Fibrillation
3:00 PM-3:45 PM
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-4:30 PM
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
4:00 PM-5:00 PM
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
 
4:30 PM-5:00 PM
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
 
5:00 PM-5:30 PM
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
5:00 PM-6:00 PM
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
 
5:30 PM-6:00 PM
Medical Brain Game: SAFE Opioid Prescribing Edition
 
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Mission Control: Medical Excellence
Room: Hall B3, Level 3
This year's keynote address will be delivered by Dr. Story Musgrave, physician astronaut, who flew on each of the 5 different NASA space shuttles and led the first repair mission to the Hubble Space Telescope. With his broad educational background that includes mathematics, operational analysis, chemistry, literature, and cardiovascular and exercise physiology, Dr. Musgrave will provide his unique perspective on the mission of achieving clinical success and optimal patient outcomes.
Learning Objectives:
  1. Consider care of all patients as an urgent mission with critical outcomes.
  2. Lead your team to ensure optimal patient outcomes through spirit, ownership, and passion for the mission.
  3. Apply the best practices, procedures, and processes to guarantee that your path to clinical success is the best available.
Faculty:
  1. Story Musgrave, MD , MS, Astronaut, NASA, Innovator, Applied Minds Inc., Professor of Design, Art Center College of DesignPasadena, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Women’s Health Update: Clinical Pearls for Primary Care
Room: Hall B3, Level 3
A review of the spectrum of common health concerns in postmenopausal women and their prevention and management.
Learning Objectives:
  1. Weigh the evidence for benefits versus harms when considering hormone replacement therapy for women with menopausal symptoms.
  2. Proactively screen and treat elderly women to prevent falls and fractures.
Faculty:
  1. Kelly Spratt, DO, FACC, FACP, Clinical Associate Professor of Medicine, University of PennsylvaniaPhiladelphia, PA (Bio)
CLOSE  X  
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
Room: George Bush Ballroom, Level 3
Cardiovascular health is increasingly becoming an issue in long-term cancer survivors, requiring closer attention to its management. Learn how to assess and address cardiovascular risk in cancer survivors.
Learning Objectives:
  1. Explore the evidence regarding cardiovascular disease in survivors of certain types of cancer.
  2. Encourage cancer survivor patients to adopt healthy lifestyles to reduce CV and cancer risk.
  3. Implement screening guidelines for cancer survivors to reduce future cancer risk.
Faculty:
  1. Kevin Oeffinger, MD, Dir., Living Beyond Cancer: A Program for Adult Survivors of Pediatric Cancer, Departments of Pediatrics and Internal Medicine, Memorial Sloan-Kettering Cancer CenterNew York, NY (Bio)
CLOSE  X  
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
Room: George Bush Ballroom, Level 3
Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis and pulmonary embolism. This session will assist you in identifying high risk medical and hospitalized patients in whom thromboprophylaxis should be initiated and appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Learning Objectives:
  1. Identify high risk medical and hospitalized patients for whom thromboprophylaxis should be initiated
  2. Determine appropriate oral regimens for extended thromboprophylaxis after hospital discharge
Faculty:
  1. Matthew Rondina, MD, Assistant Professor, University Of Utah Salt Lake City, UT, Co-Director, Healthcare Thrombosis Service, University Of Utah Salt Lake City, UT (Bio)
CLOSE  X  
Critical Caveats for Common Medications
Room: Hall B3, Level 3
Case-based review of side effects and drug interactions encountered with commonly used medications, including proton pump inhibitors, triptans, antibiotics, anticoagulants, NSAIDs and antidepressants.
Learning Objectives:
  1. Effectively manage patients who are on statin therapy with respect to potential drug interactions and muscle-related symptoms.
  2. Consider potential adverse effects of proton pump inhibitors, such as impaired absorption of certain nutrients, when prescribing as long-term therapy.
Faculty:
  1. Douglas Paauw, MD, Professor of Medicine, Rothman Family Foundation, Endowed Chair in Patient-Centered Clinical Education, University of Washington School of MedicineSeattle, WA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
Room: George Bush Ballroom, Level 3
This session will provide you with actionable information regarding insect pest borne infectious diseases, including the topic of the manifestations of Lyme disease and test interpretation to manage these patients and identifying body lice infestation with patient education regarding treatment and prevention.
Learning Objectives:
  1. Differentially diagnose common tick-borne diseases using symptomology, epidemiologic evidence, and lab tests, and prescribe antibiotic therapy as indicated.
  2. Diagnose and manage clinical manifestations of common pest infestations, including lice, mites, and bed bugs.
Faculty:
  1. Charles Davis, PhD , MD, South Texas Surgical and Spine Hospital (Bio)
CLOSE  X  
Lung Sounds: A Primer on Pulmonary Auscultation
Room: Hall B3, Level 3
This primer on pulmonary auscultation will permit you to identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently, and link them to the scientific and literature validation that supports their clinical relevancy.
Learning Objectives:
  1. Recognize and identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently.
  2. Link literature validation and scientific basis to those sounds and extra-sounds which are clinically relevant.
  3. Establish a clinico-pathologic correlation for sounds and extra-sounds and murmurs.
Faculty:
  1. Salvatore Mangione, MD, Associate Professor of Medicine, Jefferson Medical CollegePhiladelphia, PA (Bio)
CLOSE  X  
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
Room: Hall B3, Level 3
This session will provide actionable information for implementing current evidence-based guidelines to reduce CVD risk in type 2 diabetes patients and will utilize a case-based approach that addresses CV risk factors such a dyslipidemia and hypertension in these patients.
Learning Objectives:
  1. Identify key factors associated with increased cardiovascular outcomes in patients with type 2 diabetes
  2. Implement current evidence-based guidelines to reduce the risk of CV disease in patients with type 2 diabetes mellitus
Faculty:
  1. JoAnne Foody, MD, FACC, FAHA, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA, Director, Cardiovascular Wellness Program, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
Room: George Bush Ballroom, Level 3
This session will provide guidance on whom to screen for obstructive sleep apnea in your primary care practice, how to screen, interventions and the differences you will encounter between male and female patients with this condition.
Learning Objectives:
  1. Implement practice-based procedures to screen and manage patients at risk for or with evidence of obstructive sleep apnea .
  2. Co-manage patients with OSA and encourage continued monitoring and compliance with CPAP therapy.
Faculty:
  1. Jonathan Lown, MD, Adjunct Faculty, Stony Brook UniversityStony Brook, NY (Bio)
CLOSE  X  
Networking Break
CLOSE  X  
In Search of Joy in Practice: Innovations in Patient Centered Care
Room: Hall B3, Level 3
Learning Objectives:
  1. Identify 3 innovations to improve quality and satisfaction of practice
  2. Integrate cost-effective innovations into your practice
Faculty:
  1. Christine Sinsky, MD, General Internist, Medical Associates Clinic and Health PlansDubuque, IA
  2. Thomas Sinsky, MD, General Internist, Medical Associates Clinic and Health PlansDubuque, IA
CLOSE  X  
Targeting Better Cardiac Outcomes for High-Risk Patients
Room: George Bush Ballroom, Level 3
This session will provide important update information on low HDL-C levels and elevated triglycerides as therapeutic targets to reduce cardiovascular disease risk.
Learning Objectives:
  1. Evaluate recent clinical trials with respect to management of low HDL.
  2. Examine the data on triglycerides and CVD risk to determine how aggressively to treat patients with elevated TGs.
  3. Employ strategies for reducing CVD risk in patients with type 2 diabetes and hypertension.
Faculty:
  1. Peter Jones, MD, FACP, FNLA, Associate Professor, Methodist DeBakey Heart and Vascular Center, Baylor College of MedicineHouston, TX (Bio)
CLOSE  X  
Ethical Considerations in Shared Decision Making
Room: Hall B3, Level 3
This activity meets the criteria of the Texas Medical Board for 1 credit of Medical Ethics. Please check your individual state licensing board requirements before claiming Medical Ethics credit. *pmiCME designates the session Ethical Considerations in Shared Decision Making for 1.0 credit of Medical Ethics"
Learning Objectives:
  1. Understand what shared decision making is and how it is implemented.
  2. Understand the policy developments surrounding shared decision making.
  3. Explain the key ethical reasons for a move towards shared decision making.
  4. Explain the ethical challenges arising in implementation.
Faculty:
  1. Jennifer Blumenthal-Barby, PhD , MA, Assistant Professor of Medical Ethics, Center of Medical Ethics and Health Policy, Baylor College of MedicineRichmond, TX (Bio)
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Mission Control: Medical Excellence
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Women’s Health Update: Clinical Pearls for Primary Care
9:45 AM-10:45 AM
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
 
 
 
10:45 AM-11:45 AM
Critical Caveats for Common Medications
10:45 AM-11:45 AM
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:45 PM
Lung Sounds: A Primer on Pulmonary Auscultation
1:45 PM-2:45 PM
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
 
 
 
2:45 PM-3:45 PM
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
2:45 PM-3:45 PM
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
 
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-5:00 PM
In Search of Joy in Practice: Innovations in Patient Centered Care
4:00 PM-5:00 PM
Targeting Better Cardiac Outcomes for High-Risk Patients
 
 
 
5:00 PM-6:00 PM
Ethical Considerations in Shared Decision Making
 
 
 

Ticketed Events

For 2014, Pri-Med is implementing a new ticketing policy to give all attendees equal opportunity to attend the additional events within the conference. Distribution of all additional opportunity tickets will happen on-site on a first-come, first-served basis at the Ticket Booth. Please check-in early to ensure tickets are available for the additional opportunities you want to participate in.

Ticket Booth Hours
Thursday, March 20: 6:30am–4:30pm
Friday, March 21: 6:45am–2pm
Saturday, March 22: 6:45am–2pm

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Pancreatic Insufficiency

8:55 AM-9:40 AM

Lipids

Lunch Break

CME Educational Symposia

12:00 PM-1:30 PM

Non-CME Presentation Theater

11:50 AM-12:35 PM

Cardiac Imaging

11:50 AM-12:35 PM

COPD

11:50 AM-12:35 PM

Obesity

Lunch Break 2

Non-CME Presentation Theater

12:55 PM-1:40 PM

Diabetes

12:55 PM-1:40 PM

Hep C

Dinner

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Men's Health

8:55 AM-9:40 AM

Diabetes

Lunch Break

Non-CME Presentation Theater

11:50 AM-12:35 PM

Gastro

11:50 AM-12:35 PM

Afib/Stroke

11:50 AM-12:35 PM

Dupuytren's Contracture

11:50 AM-12:35 PM

Back Pain

Lunch

CME Educational Symposia

12:00 PM-1:30 PM

Diabetes

Lunch Break 2

Non-CME Presentation Theater

12:55 PM-1:40 PM

Respiratory

CLOSE  X  
Understanding the Data - Exocrine Pancreatic Insufficiency
Room: Theater 2
Faculty:
  1. Lawrence Schiller, MD, FACS (Bio)
CLOSE  X  
The Importance of Treating High Triglycerides
Room: Theater 1
Faculty:
  1. Michael Cobble, MD
CLOSE  X  
RAPID - Rheumatoid Arthritis: A Primary Care Initiative for Improved Diagnosis and Outcomes
Room: Ballroom C, Level 3
Learning Objectives:
  1. Identify patients who have early RA by incorporating simple screening tests into daily practice
  2. Employ the squeeze test to assist with diagnosis of RA
  3. Order appropriate laboratory tests when RA is suspected
  4. Appropriately manage infections in patients taking DMARD therapy
  5. Assess and aggressively reduce CVD risk in RA patients
Faculty:
  1. Paul Doghramji, FAAFP , MD, Medical Director of Health Services, Ursinus CollegeCollegeville, PA, Family Physician, Collegeville Family PracticeCollegeville, PA (Bio)
  2. Sandeep Krishna Agarwal, PhD, MD, Associate Professor, Department of Medicine, Section of Immunology, Allergy and Rheumatology, Department of Pathology & Immunology, Baylor College of MedicineRichmond, TX
  3. Lisa Diven, Director of the Women’s Intersport Network, Kansas City Sports Commission
The CME activity is supported by an educational grant from Supported by independent educational grants from Abbvie and Janssen Biotech .
CLOSE  X  
Evaluating and Determining Patients for Cardiac Radionuclide Imaging
Room: Theater 1
Faculty:
  1. Diwakar Jain, MD, FACC, FRCP
CLOSE  X  
COPD Care: Insights on Treatment Options An Open Gallery Event
Room: Room 310A
Faculty:
  1. Richard Powell
  2. Michael Zack, MD, PC
CLOSE  X  
A Novel Treatment Option for Chronic Weight Management
Room: Theater 2
CLOSE  X  
Advancing Paradigm Changes in Type 2 Diabetes Management
Room: Theater 2
Faculty:
  1. Robert Guthrie, MD
CLOSE  X  
Rethink HCV
Room: Theater 1
Faculty:
  1. Imtiaz Alam
CLOSE  X  
Men’s Health Care Spotlight: The Management and Treatment of Erectile Dysfunction
Room: Theater 2
Faculty:
  1. Larry Lipshultz, MD
CLOSE  X  
The Role the Kidney Plays in the Pathophysiology of Diabetes Type 2 Mellitus
Room: Theater 1
Faculty:
  1. Neil Kaminsky
CLOSE  X  
Hepatic Encephalopathy: A Clinical Dialogue on a Chronic Complication of Cirrhosis
Room: Theater 2
Hepatic encephalopathy (HE) is a chronic complication of cirrhosis that causes a variety of mental and physical symptoms. HE can occur in up to 45% of patients with cirrhosis. It is a debilitating condition marked by a cycle of remission followed by recurrence that is difficult to break. This program explores a twice-daily therapy for reducing the risk of HE recurrence.
Faculty:
  1. Fred Poordad, MD
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Room: Theater 1
Faculty:
  1. Alan Jacobson, FACC , MD
CLOSE  X  
Dupuytren's Contracture in Adults with a Palpable Cord: Clinical Overview and Treatment Options
Room: Room 310A
Faculty:
  1. Nicholas Fiore, MD
CLOSE  X  
Inflammatory Back Pain Recognition and Diagnosis
Room: Theater 1
Faculty:
  1. Prashanth Sunkureddi, MD
CLOSE  X  
Managing the Risk of Hypoglycemia in the Patient with Type 2 DM
Room: Ballroom C, Level 3
Learning Objectives:
  1. Assess the results and explain the clinical implications of ACCORD, ADVANCE, and VADT studies.
  2. Identify risk factors that are associated with hypoglycemia in patient with type 2 diabetes and the importance of individualize glycemic targets.
  3. Describe special patient groups who are at an increase risk of adverse outcomes due to hypoglycemia.
  4. Outline current available antihyperglycemic agents that do not promote hypoglycemia.
  5. Device regimens that employ complimentary antihyperglycemic agents to optimize glycemic control while minimizing hypoglycemia risk in patients with type 2 diabetes.
Faculty:
  1. Frank Lavernia, MD, Founder and Director, North Broward Diabetes CenterPompano Beach, FL (Bio)
  2. Dace Trence, MD, FACE, Director, Diabetes Care Center, Professor, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medical CenterSeattle, WA
The CME activity is supported by an educational grant from Merck & Co., Inc..
CLOSE  X  
The Latest Information in Therapy for Asthma, COPD, and Exercise-Induced Bronchospasm
Room: Theater 2
Faculty:
  1. Lewis Brown

Accreditation

Earn up to 20.75 AMA PRA Category 1 Credits™ or 20.75 AANP contact hours of continuing education.

Primary Care Updates—Track One
March 20, 2014
Credits Type Accreditation Statement Designation Statement
6.5 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.5 AAFP This live activity, Primary Care Updates – Track One, with a begin date of 3/20/2014, has been reviewed and is acceptable for up to 6.5 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.5 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.5 contact hours of continuing education (which includes 3.250 hours of pharmacology).
Primary Care Updates—Track Two
March 20, 2014
Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AAFP This live activity, Primary Care Updates – Track Two, with a begin date of 3/20/2014, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).
Annual Conference
March 21—22, 2014
Credits Type Accreditation Statement Designation Statement
14 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
14 AAFP This live activity, Southwest Annual Conference, with a begin date of 3/21/2014, has been reviewed and is acceptable for up to 14 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
14 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 14 contact hours of continuing education (which includes 7.000 hours of pharmacology).

Keynote Speakers

Michael Dansinger, MD (Read Bio)

Tufts Medical Center, Boston, MA

Presenting on:

Story Musgrave, MD, MS (Read Bio)

NASA,
Applied Minds Inc.,
Art Center College of Design, Pasadena, CA

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Thursday, March 20 3:30–6pm
Friday, March 21 8:30am–2:30pm
Saturday, March 22 8:30am–2pm

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

Pri-Med Mobile App Available Now!

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.

Exhibitor List

Company Name Booth Number
AbbVie 103
Alcat Worldwide 225
Amazing Charts 201
American Express Open 726
AstraZeneca/BMS Alliance 209
Auxilium Pharmaceuticals, Inc. 426
Bionix Medical Technologies 404
Calmoseptine, Inc. 110
Civilian Corps US Army Medical Command 700
Concentra Primary Care 626
CryoSurgery, Inc 219
Dermalogix Partners Inc 505
Eisai, Inc. 417
e-MDs 126
Forest Pharmaceuticals, Inc. 109
Gensco Laboratories 330
Grifols USA, LLC. 526
Health Diagnostic Laboratory, Inc. 226
i-Lipo / Chromogenex 605
Janssen Pharmaceuticals, Inc. 508
Laclede Inc 503
Lippincott Williams & Wilkins 108
Magine Events 710
MD Anderson Cancer Center 525
Medical Device Division of OAPI, Inc. 301
MediTouch EHR / HealthFusion 704
Migraine Relief Center 731
Monthly Prescribing Reference 702
Nova Medical Centers 427
Orasure Technologies, Inc. 524
Personna 630
Pri-Med Solutions Center 105
Salix Pharmaceuticals, Inc. 325
Shire 500
Summit Doppler Systems 709
Teva Respiratory 501
The Inline Group 701
Unicity International 530
Venus Concept 227
Whitaker Medical 223
Company Name Booth Number
AbbVie 309
Amarin Pharma, Inc. 430
American College of Physicians 601
Arbor Pharmaceuticals, Inc. 431
Auxilium Pharmaceuticals, Inc. 131
Baylor College of Medicine - Smith Breast Center 705
Boulder Diagnostics Inc 125
Christus Health 127
Community Medical Group 130
CryoProbe 604
Daiichi Sankyo, Inc. 303
Diva International Inc. 326
Elsevier Medical Books 104
Endothelix, Inc. 101
Genova Diagnostics, Inc 331
Gilead Sciences 617
HAE: Learn About It, Talk About It 424
Hemosure 722
Infinite Therapeutics 623
Kareo 531
Life Extension 711
Magic Massage Therapy 631
Maico Diagnostics 217
Mederi Therapeutics, Inc 402
Medifr 425
Micro Direct, Inc. 708
Mission Pharmacal Co 112
Neilmed Pharmaceuticals, Inc. 717
Novartis Pharmaceuticals Corporation 403
Otto Trading, Inc. 724
Pri-Med Recharge Lounge 317
Qiagen, Inc. 100
Shader Productions 730
Spectrum Neurology Group, LLC 527
Take Care Health Systems 600
The Gideons International 727
Ultimate Creations 723
Vein Clinics of America 231
Vitamix 627
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

George R. Brown Convention Center
1001 Avenida de las Americas
Houston, TX 77010-6032
(800) 427-4697

Hotel Accommodations

Good Health Begins Here